Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-wave Myocardial Infarction by MRI
- Conditions
- Coronary ArteriosclerosisMyocardial Infarction
- Registration Number
- NCT00493168
- Lead Sponsor
- Duke University
- Brief Summary
The first aim of this study is to determine how often unrecognized myocardial infarction occur in patients using a magnetic resonance imaging (MRI) technique (known as delayed enhancement MRI), as compared to the electrocardiogram. The second aim of this study is to determine the severity of coronary heart disease of the patients with unrecognized myocardial infarction. The final aim is to determine how the presence of unrecognized myocardial infarction detected by the MRI affects lifespan.
- Detailed Description
Unrecognized myocardial infarction (MI) is known to constitute a substantial portion of lethal coronary heart disease. However, since the diagnosis of unrecognized MI is based on the appearance of incidental Q-waves on 12-lead electrocardiography, the syndrome of unrecognized non-Q-wave MI has not been described. Delayed-enhancement cardiovascular magnetic resonance (DE-CMR) can accurately identify non-Q-wave MI. The aims of this study are three-fold: 1. to determine the prevalence of unrecognized non-Q-wave and Q-wave MI, 2. to define predictors of unrecognized non-Q-wave MI, 3. to determine the prognostic significance of unrecognized non-Q-wave MI.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 185
- Patients with suspected coronary artery disease referred for invasive coronary angiography
- Clinical history of myocardial infarction
- Percutaneous coronary intervention
- Coronary artery bypass surgery
- Known uncured malignancy
- History of hypertrophic cardiomyopathy, myocarditis, or infiltrative heart disease
- Contraindication of magnetic resonance imaging
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Duke Cardiovascular Magnetic Resonance Center
🇺🇸Durham, North Carolina, United States
Northwestern University Medical School
🇺🇸Chicago, Illinois, United States